HEADER HYDROLASE/INHIBITOR 28-JUN-23 8TBG
TITLE TRICOMPLEX OF RMC-7977, HRAS WT, AND CYPA
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: GTPASE HRAS;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: H-RAS-1,HA-RAS,TRANSFORMING PROTEIN P21,C-H-RAS,P21RAS;
COMPND 5 ENGINEERED: YES;
COMPND 6 MOL_ID: 2;
COMPND 7 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A;
COMPND 8 CHAIN: C, D;
COMPND 9 SYNONYM: PPIASE A,CYCLOPHILIN A,CYCLOSPORIN A-BINDING PROTEIN,
COMPND 10 ROTAMASE A;
COMPND 11 EC: 5.2.1.8;
COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: HRAS, HRAS1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 MOL_ID: 2;
SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 10 ORGANISM_COMMON: HUMAN;
SOURCE 11 ORGANISM_TAXID: 9606;
SOURCE 12 GENE: PPIA, CYPA;
SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS INHIBITOR, COMPLEX, SMALL GTPASE, CANCER, TRICOMPLEX, HYDROLASE-
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.CHEN,A.C.A.TOMLINSON,J.E.KNOX,J.K.YANO
REVDAT 3 05-JUN-24 8TBG 1 JRNL
REVDAT 2 24-APR-24 8TBG 1 JRNL
REVDAT 1 07-FEB-24 8TBG 0
JRNL AUTH M.HOLDERFIELD,B.J.LEE,J.JIANG,A.TOMLINSON,K.J.SEAMON,A.MIRA,
JRNL AUTH 2 E.PATRUCCO,G.GOODHART,J.DILLY,Y.GINDIN,N.DINGLASAN,Y.WANG,
JRNL AUTH 3 L.P.LAI,S.CAI,L.JIANG,N.NASHOLM,N.SHIFRIN,C.BLAJ,H.SHAH,
JRNL AUTH 4 J.W.EVANS,N.MONTAZER,O.LAI,J.SHI,E.AHLER,E.QUINTANA,S.CHANG,
JRNL AUTH 5 A.SALVADOR,A.MARQUEZ,J.CREGG,Y.LIU,A.MILIN,A.CHEN,T.B.ZIV,
JRNL AUTH 6 D.PARSONS,J.E.KNOX,J.E.KLOMP,J.ROTH,M.REES,M.RONAN,
JRNL AUTH 7 A.CUEVAS-NAVARRO,F.HU,P.LITO,D.SANTAMARIA,A.J.AGUIRRE,
JRNL AUTH 8 A.M.WATERS,C.J.DER,C.AMBROGIO,Z.WANG,A.L.GILL,E.S.KOLTUN,
JRNL AUTH 9 J.A.M.SMITH,D.WILDES,M.SINGH
JRNL TITL CONCURRENT INHIBITION OF ONCOGENIC AND WILD-TYPE RAS-GTP FOR
JRNL TITL 2 CANCER THERAPY.
JRNL REF NATURE V. 629 919 2024
JRNL REFN ESSN 1476-4687
JRNL PMID 38589574
JRNL DOI 10.1038/S41586-024-07205-6
REMARK 2
REMARK 2 RESOLUTION. 1.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.20.1_4487
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.29
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5
REMARK 3 NUMBER OF REFLECTIONS : 211141
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.162
REMARK 3 R VALUE (WORKING SET) : 0.161
REMARK 3 FREE R VALUE : 0.192
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030
REMARK 3 FREE R VALUE TEST SET COUNT : 10617
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 58.2900 - 3.7300 1.00 7140 379 0.1513 0.1716
REMARK 3 2 3.7300 - 2.9600 1.00 6880 356 0.1539 0.1693
REMARK 3 3 2.9600 - 2.5900 1.00 6817 377 0.1597 0.1887
REMARK 3 4 2.5900 - 2.3500 1.00 6776 367 0.1536 0.1815
REMARK 3 5 2.3500 - 2.1800 1.00 6756 355 0.1401 0.1706
REMARK 3 6 2.1800 - 2.0500 1.00 6748 363 0.1356 0.1647
REMARK 3 7 2.0500 - 1.9500 1.00 6748 347 0.1332 0.1642
REMARK 3 8 1.9500 - 1.8600 1.00 6752 342 0.1390 0.1698
REMARK 3 9 1.8600 - 1.7900 1.00 6682 368 0.1378 0.1785
REMARK 3 10 1.7900 - 1.7300 1.00 6700 369 0.1321 0.1759
REMARK 3 11 1.7300 - 1.6800 1.00 6690 353 0.1404 0.1917
REMARK 3 12 1.6800 - 1.6300 1.00 6703 348 0.1379 0.1812
REMARK 3 13 1.6300 - 1.5900 1.00 6693 347 0.1393 0.2001
REMARK 3 14 1.5900 - 1.5500 1.00 6676 375 0.1483 0.1903
REMARK 3 15 1.5500 - 1.5100 1.00 6683 352 0.1629 0.1990
REMARK 3 16 1.5100 - 1.4800 1.00 6674 357 0.1713 0.2225
REMARK 3 17 1.4800 - 1.4500 1.00 6695 325 0.1790 0.2194
REMARK 3 18 1.4500 - 1.4200 1.00 6640 330 0.1852 0.2515
REMARK 3 19 1.4200 - 1.4000 1.00 6666 363 0.1903 0.2318
REMARK 3 20 1.4000 - 1.3700 1.00 6688 342 0.1919 0.2348
REMARK 3 21 1.3700 - 1.3500 1.00 6626 359 0.2059 0.2410
REMARK 3 22 1.3500 - 1.3300 1.00 6645 364 0.2151 0.2522
REMARK 3 23 1.3300 - 1.3100 1.00 6646 343 0.2231 0.2700
REMARK 3 24 1.3100 - 1.2900 1.00 6642 365 0.2343 0.2743
REMARK 3 25 1.2900 - 1.2800 1.00 6646 365 0.2563 0.3106
REMARK 3 26 1.2800 - 1.2600 1.00 6617 335 0.2685 0.3061
REMARK 3 27 1.2600 - 1.2400 0.98 6498 342 0.2758 0.2908
REMARK 3 28 1.2400 - 1.2300 0.98 6520 377 0.2863 0.3204
REMARK 3 29 1.2300 - 1.2100 0.98 6467 343 0.3049 0.3415
REMARK 3 30 1.2100 - 1.2000 0.96 6410 309 0.3250 0.3715
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.10
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.910
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 13.40
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.72
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.006 5686
REMARK 3 ANGLE : 0.896 7723
REMARK 3 CHIRALITY : 0.079 817
REMARK 3 PLANARITY : 0.005 1005
REMARK 3 DIHEDRAL : 13.580 2185
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8TBG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-23.
REMARK 100 THE DEPOSITION ID IS D_1000275602.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 05-MAY-23
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : CLSI
REMARK 200 BEAMLINE : 08ID-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.95371
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 211361
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200
REMARK 200 RESOLUTION RANGE LOW (A) : 58.290
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5
REMARK 200 DATA REDUNDANCY : 7.100
REMARK 200 R MERGE (I) : 0.09715
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.2200
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2
REMARK 200 DATA REDUNDANCY IN SHELL : 4.80
REMARK 200 R MERGE FOR SHELL (I) : 0.72500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.820
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 46.26
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 28% PEG4000, 0.1 M TRIS, PH 8, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.72500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.10450
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.43000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.10450
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.72500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.43000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER C 0
REMARK 465 SER D 0
REMARK 465 MET D 1
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ILE A 36 -70.09 -89.03
REMARK 500 LYS A 117 32.76 70.52
REMARK 500 ARG A 149 -5.77 79.75
REMARK 500 LYS B 117 31.08 74.10
REMARK 500 LYS B 117 30.59 74.10
REMARK 500 PHE C 60 -67.65 -132.42
REMARK 500 PHE C 60 -68.15 -132.42
REMARK 500 LYS C 133 -60.01 -95.56
REMARK 500 PHE D 60 -67.68 -133.43
REMARK 500 PHE D 60 -65.94 -133.43
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH D 515 DISTANCE = 6.16 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG A 202 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 SER A 17 OG
REMARK 620 2 THR A 35 OG1 82.4
REMARK 620 3 GNP A 201 O1G 171.9 89.7
REMARK 620 4 GNP A 201 O2B 92.6 174.9 95.4
REMARK 620 5 HOH A 324 O 86.1 89.6 92.4 90.8
REMARK 620 6 HOH A 360 O 87.7 90.3 93.8 88.8 173.8
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG B 202 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 SER B 17 OG
REMARK 620 2 THR B 35 OG1 81.2
REMARK 620 3 GNP B 201 O1G 171.7 90.6
REMARK 620 4 GNP B 201 O2B 93.1 173.8 95.1
REMARK 620 5 HOH B 341 O 86.6 91.7 92.2 90.5
REMARK 620 6 HOH B 358 O 87.8 88.6 93.5 88.6 174.3
REMARK 620 N 1 2 3 4 5
DBREF 8TBG A 1 166 UNP P01112 RASH_HUMAN 1 166
DBREF 8TBG B 1 166 UNP P01112 RASH_HUMAN 1 166
DBREF 8TBG C 1 165 UNP P62937 PPIA_HUMAN 1 165
DBREF 8TBG D 1 165 UNP P62937 PPIA_HUMAN 1 165
SEQADV 8TBG GLY A 0 UNP P01112 EXPRESSION TAG
SEQADV 8TBG GLY B 0 UNP P01112 EXPRESSION TAG
SEQADV 8TBG SER C 0 UNP P62937 EXPRESSION TAG
SEQADV 8TBG SER D 0 UNP P62937 EXPRESSION TAG
SEQRES 1 A 167 GLY MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA GLY
SEQRES 2 A 167 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN
SEQRES 3 A 167 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP
SEQRES 4 A 167 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS
SEQRES 5 A 167 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR
SEQRES 6 A 167 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY
SEQRES 7 A 167 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE
SEQRES 8 A 167 GLU ASP ILE HIS GLN TYR ARG GLU GLN ILE LYS ARG VAL
SEQRES 9 A 167 LYS ASP SER ASP ASP VAL PRO MET VAL LEU VAL GLY ASN
SEQRES 10 A 167 LYS CYS ASP LEU ALA ALA ARG THR VAL GLU SER ARG GLN
SEQRES 11 A 167 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO TYR ILE
SEQRES 12 A 167 GLU THR SER ALA LYS THR ARG GLN GLY VAL GLU ASP ALA
SEQRES 13 A 167 PHE TYR THR LEU VAL ARG GLU ILE ARG GLN HIS
SEQRES 1 B 167 GLY MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA GLY
SEQRES 2 B 167 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN
SEQRES 3 B 167 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP
SEQRES 4 B 167 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS
SEQRES 5 B 167 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR
SEQRES 6 B 167 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY
SEQRES 7 B 167 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE
SEQRES 8 B 167 GLU ASP ILE HIS GLN TYR ARG GLU GLN ILE LYS ARG VAL
SEQRES 9 B 167 LYS ASP SER ASP ASP VAL PRO MET VAL LEU VAL GLY ASN
SEQRES 10 B 167 LYS CYS ASP LEU ALA ALA ARG THR VAL GLU SER ARG GLN
SEQRES 11 B 167 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO TYR ILE
SEQRES 12 B 167 GLU THR SER ALA LYS THR ARG GLN GLY VAL GLU ASP ALA
SEQRES 13 B 167 PHE TYR THR LEU VAL ARG GLU ILE ARG GLN HIS
SEQRES 1 C 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL
SEQRES 2 C 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE
SEQRES 3 C 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA
SEQRES 4 C 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER
SEQRES 5 C 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY
SEQRES 6 C 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER
SEQRES 7 C 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU
SEQRES 8 C 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA
SEQRES 9 C 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR
SEQRES 10 C 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE
SEQRES 11 C 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET
SEQRES 12 C 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS
SEQRES 13 C 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU
SEQRES 1 D 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL
SEQRES 2 D 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE
SEQRES 3 D 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA
SEQRES 4 D 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER
SEQRES 5 D 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY
SEQRES 6 D 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER
SEQRES 7 D 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU
SEQRES 8 D 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA
SEQRES 9 D 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR
SEQRES 10 D 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE
SEQRES 11 D 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET
SEQRES 12 D 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS
SEQRES 13 D 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU
HET GNP A 201 32
HET MG A 202 1
HET GNP B 201 32
HET MG B 202 1
HET GOL C 201 6
HET ZNI C 202 62
HET ZNI D 201 62
HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER
HETNAM MG MAGNESIUM ION
HETNAM GOL GLYCEROL
HETNAM ZNI (1R,5S,6R)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-
HETNAM 2 ZNI CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-
HETNAM 3 ZNI METHOXYETHYL]PYRIDIN-3-YL}-21-ETHYL-17,17-DIMETHYL-8,
HETNAM 4 ZNI 14-DIOXO-15-OXA-4-THIA-9,21,27,28-
HETNAM 5 ZNI TETRAAZAPENTACYCLO[17.5.2.1~2,5~.1~9,13~.0~22,
HETNAM 6 ZNI 26~]OCTACOSA-1(24),2,5(28),19,22,25-HEXAEN-7-YL]-3-
HETNAM 7 ZNI OXABICYCLO[3.1.0]HEXANE-6-CARBOXAMIDE
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
HETSYN ZNI RMC-7977
FORMUL 5 GNP 2(C10 H17 N6 O13 P3)
FORMUL 6 MG 2(MG 2+)
FORMUL 9 GOL C3 H8 O3
FORMUL 10 ZNI 2(C47 H60 N8 O6 S)
FORMUL 12 HOH *846(H2 O)
HELIX 1 AA1 GLY A 15 ASN A 26 1 12
HELIX 2 AA2 GLN A 61 MET A 67 5 7
HELIX 3 AA3 ARG A 68 GLY A 75 1 8
HELIX 4 AA4 ASN A 86 ASP A 92 1 7
HELIX 5 AA5 ASP A 92 ASP A 105 1 14
HELIX 6 AA6 GLU A 126 GLY A 138 1 13
HELIX 7 AA7 GLY A 151 GLN A 165 1 15
HELIX 8 AA8 GLY B 15 ASN B 26 1 12
HELIX 9 AA9 GLN B 61 MET B 67 5 7
HELIX 10 AB1 ARG B 68 GLY B 75 1 8
HELIX 11 AB2 ASN B 86 ASP B 92 1 7
HELIX 12 AB3 ASP B 92 ASP B 105 1 14
HELIX 13 AB4 GLU B 126 GLY B 138 1 13
HELIX 14 AB5 GLY B 151 GLN B 165 1 15
HELIX 15 AB6 VAL C 29 GLY C 42 1 14
HELIX 16 AB7 THR C 119 ASP C 123 5 5
HELIX 17 AB8 GLY C 135 GLU C 143 1 9
HELIX 18 AB9 ARG C 144 GLY C 146 5 3
HELIX 19 AC1 VAL D 29 GLY D 42 1 14
HELIX 20 AC2 THR D 119 ASP D 123 5 5
HELIX 21 AC3 GLY D 135 GLU D 143 1 9
HELIX 22 AC4 ARG D 144 GLY D 146 5 3
SHEET 1 AA1 6 GLU A 37 ILE A 46 0
SHEET 2 AA1 6 GLU A 49 THR A 58 -1 O LEU A 53 N LYS A 42
SHEET 3 AA1 6 THR A 2 GLY A 10 1 N TYR A 4 O ASP A 54
SHEET 4 AA1 6 GLY A 77 ALA A 83 1 O LEU A 79 N VAL A 9
SHEET 5 AA1 6 MET A 111 ASN A 116 1 O ASN A 116 N PHE A 82
SHEET 6 AA1 6 TYR A 141 GLU A 143 1 O ILE A 142 N LEU A 113
SHEET 1 AA2 6 GLU B 37 ILE B 46 0
SHEET 2 AA2 6 GLU B 49 THR B 58 -1 O LEU B 53 N LYS B 42
SHEET 3 AA2 6 THR B 2 GLY B 10 1 N TYR B 4 O ASP B 54
SHEET 4 AA2 6 GLY B 77 ALA B 83 1 O LEU B 79 N VAL B 9
SHEET 5 AA2 6 MET B 111 ASN B 116 1 O ASN B 116 N PHE B 82
SHEET 6 AA2 6 TYR B 141 GLU B 143 1 O ILE B 142 N LEU B 113
SHEET 1 AA3 8 PHE C 53 ILE C 57 0
SHEET 2 AA3 8 MET C 61 GLY C 64 -1 O GLN C 63 N ARG C 55
SHEET 3 AA3 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62
SHEET 4 AA3 8 ILE C 97 MET C 100 -1 N ILE C 97 O CYS C 115
SHEET 5 AA3 8 VAL C 128 GLU C 134 -1 O GLY C 130 N LEU C 98
SHEET 6 AA3 8 GLU C 15 LEU C 24 -1 N SER C 21 O LYS C 133
SHEET 7 AA3 8 THR C 5 VAL C 12 -1 N ILE C 10 O LEU C 17
SHEET 8 AA3 8 ILE C 156 GLU C 165 -1 O ASP C 160 N ASP C 9
SHEET 1 AA4 8 ARG D 55 ILE D 57 0
SHEET 2 AA4 8 MET D 61 GLY D 64 -1 O GLN D 63 N ARG D 55
SHEET 3 AA4 8 PHE D 112 CYS D 115 -1 O ILE D 114 N CYS D 62
SHEET 4 AA4 8 ILE D 97 MET D 100 -1 N ILE D 97 O CYS D 115
SHEET 5 AA4 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98
SHEET 6 AA4 8 GLU D 15 LEU D 24 -1 N SER D 21 O LYS D 133
SHEET 7 AA4 8 THR D 5 VAL D 12 -1 N ILE D 10 O GLY D 18
SHEET 8 AA4 8 ILE D 156 LEU D 164 -1 O ASP D 160 N ASP D 9
LINK OG SER A 17 MG MG A 202 1555 1555 2.04
LINK OG1 THR A 35 MG MG A 202 1555 1555 2.08
LINK O1G GNP A 201 MG MG A 202 1555 1555 1.98
LINK O2B GNP A 201 MG MG A 202 1555 1555 2.05
LINK MG MG A 202 O HOH A 324 1555 1555 2.10
LINK MG MG A 202 O HOH A 360 1555 1555 2.10
LINK OG SER B 17 MG MG B 202 1555 1555 2.07
LINK OG1 THR B 35 MG MG B 202 1555 1555 2.06
LINK O1G GNP B 201 MG MG B 202 1555 1555 2.00
LINK O2B GNP B 201 MG MG B 202 1555 1555 2.02
LINK MG MG B 202 O HOH B 341 1555 1555 2.03
LINK MG MG B 202 O HOH B 358 1555 1555 2.12
CRYST1 65.450 80.860 128.209 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015279 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012367 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007800 0.00000